Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation

Published:2016-04 Issue:4 Volume:100 Page:933-942
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Lo Phillip,Sharma Ankit,Craig Jonathan C.,Wyburn Kate,Lim Wai,Chapman Jeremy R.,Palmer Suetonia C.,Strippoli Giovanni F. M.,Wong Germaine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference48 articles.

1. Innovative strategies in living donor kidney transplantation;Segev;Nat Rev Nephrol,2012

2. Utilization and outcomes of kidney paired donation in the United States;Segev;Transplantation,2008

3. Current status of organ transplantation in Japan;Egawa;Am J Transplant,2012

4. ABO-incompatible organ transplantation;Subramanian;Int J Immunogenet,2012

5. ABO-incompatible transplantation—a safe way to perform renal transplantation?;Beimler;Nephrol Dial Transplant,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Success in the ABO-Incompatible Kidney Transplantation: A Case Report;Cureus;2024-06-14

2. ABO-incompatible kidney transplantation using immunoadsorption columns: First experiences in South Africa;South African Medical Journal;2024-04-24

3. Outcome of ABO-incompatible Live Donor Renal Transplant: Our Experience in Tertiary Care Center of Northwest India;Journal of Mahatma Gandhi University of Medical Sciences and Technology;2024-04-20

4. Non-antigen-specific Immunoadsorption Is a Risk Factor for Severe Postoperative Infections in ABO-Incompatible Kidney Transplant Recipients;Transplant International;2024-03-14

5. Comparative analysis of Basiliximab and Alemtuzumab induction therapies in blood type A2-to-B kidney transplantation: Impact on kidney function and de novo donor-specific HLA antibodies;Transplant Immunology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3